Review Article | Published:

Nonsense-mediated mRNA decay: an intricate machinery that shapes transcriptomes

Nature Reviews Molecular Cell Biology volume 16, pages 665677 (2015) | Download Citation

Subjects

Abstract

Nonsense-mediated mRNA decay (NMD) is probably the best characterized eukaryotic RNA degradation pathway. Through intricate steps, a set of NMD factors recognize and degrade mRNAs with translation termination codons that are positioned in abnormal contexts. However, NMD is not only part of a general cellular quality control system that prevents the production of aberrant proteins. Mammalian cells also depend on NMD to dynamically adjust their transcriptomes and their proteomes to varying physiological conditions. In this Review, we discuss how NMD targets mRNAs, the types of mRNAs that are targeted, and the roles of NMD in cellular stress, differentiation and maturation processes.

Key points

  • Nonsense-mediated mRNA decay (NMD) degrades mRNAs with translation termination codons in abnormal contexts.

  • NMD targets mRNAs encoding truncated proteins with no or undesired functions, thereby preventing the accumulation of such transcripts and of the potentially aberrant proteins that they encode.

  • NMD targets some mRNAs with intact open reading frames, thereby directly affecting gene expression programmes.

  • NMD reduces the levels of mRNAs related to various normal cellular processes, through its interplay with programmed DNA rearrangements, changes in pre-mRNA processing or reprogramming of mRNA translation.

  • NMD is essential for embryogenesis and other developmental processes.

  • Upregulation and downregulation of NMD are essential for an efficient cellular response to stress and for its subsequent alleviation, respectively.

Access optionsAccess options

Rent or Buy article

Get time limited or full article access on ReadCube.

from$8.99

All prices are NET prices.

References

  1. 1.

    & Protecting the proteome: eukaryotic cotranslational quality control pathways. J. Cell Biol. 204, 467–476 (2014).

  2. 2.

    & mRNP quality control goes regulatory. Trends Genet. 28, 70–77 (2012).

  3. 3.

    & NMD: a multifaceted response to premature translational termination. Nat. Rev. Mol. Cell Biol. 13, 700–712 (2012).

  4. 4.

    , , , & Nonsense-mediated mRNA decay — mechanisms of substrate mRNA recognition and degradation in mammalian cells. Biochim. Biophys. Acta 1829, 612–623 (2013).

  5. 5.

    & Organizing principles of mammalian nonsense-mediated mRNA decay. Annu. Rev. Genet. 47, 139–165 (2013).

  6. 6.

    & Nonsense-mediated RNA decay — a switch and dial for regulating gene expression. Bioessays 37, 612–623 (2015).

  7. 7.

    , & Proteins involved in the degradation of cytoplasmic mRNA in the major eukaryotic model systems. RNA Biol. 11, 1122–1136 (2014).

  8. 8.

    , & Genetic and biochemical characterization of mutations in the ATPase and helicase regions of the Upf1 protein. Mol. Cell. Biol. 16, 5477–5490 (1996).

  9. 9.

    et al. Binding of a novel SMG-1–Upf1–eRF1–eRF3 complex (SURF) to the exon junction complex triggers Upf1 phosphorylation and nonsense-mediated mRNA decay. Genes Dev. 20, 355–367 (2006).

  10. 10.

    , & Upf1 ATPase-dependent mRNP disassembly is required for completion of nonsense-mediated mRNA decay. Cell 143, 938–950 (2010).

  11. 11.

    et al. A post-translational regulatory switch on UPF1 controls targeted mRNA degradation. Genes Dev. 28, 1900–1916 (2014).

  12. 12.

    , , , & Human SMG-1, a novel phosphatidylinositol 3-kinase-related protein kinase, associates with components of the mRNA surveillance complex and is involved in the regulation of nonsense-mediated mRNA decay. Genes Dev. 15, 2215–2228 (2001).

  13. 13.

    et al. Phosphorylation of hUPF1 induces formation of mRNA surveillance complexes containing hSMG-5 and hSMG-7. Mol. Cell 12, 1187–1200 (2003).

  14. 14.

    , & Human Upf proteins target an mRNA for nonsense-mediated decay when bound downstream of a termination codon. Cell 103, 1121–1131 (2000).

  15. 15.

    , , , & Identification and characterization of human orthologues to Saccharomyces cerevisiae Upf2 protein and Upf3 protein (Caenorhabditis elegans SMG-4). Mol. Cell. Biol. 21, 209–223 (2001).

  16. 16.

    et al. The cryo-EM structure of the UPF–EJC complex shows UPF1 poised toward the RNA 3′ end. Nat. Struct. Mol. Biol. 19, 498–505 (2012).

  17. 17.

    et al. Exon–junction complex components specify distinct routes of nonsense-mediated mRNA decay with differential cofactor requirements. Mol. Cell 20, 65–75 (2005).

  18. 18.

    et al. An alternative branch of the nonsense-mediated decay pathway. EMBO J. 26, 1820–1830 (2007).

  19. 19.

    , , , & Interactions between UPF1, eRFs, PABP and the exon junction complex suggest an integrated model for mammalian NMD pathways. EMBO J. 27, 736–747 (2008).

  20. 20.

    et al. RNA homeostasis governed by cell type-specific and branched feedback loops acting on NMD. Mol. Cell 43, 950–961 (2011).

  21. 21.

    , , & Comparison of EJC-enhanced and EJC-independent NMD in human cells reveals two partially redundant degradation pathways. RNA 19, 1432–1448 (2013).

  22. 22.

    , , , & 3′ UTR length and messenger ribonucleoprotein composition determine endocleavage efficiencies at termination codons. Cell Rep. 9, 555–568 (2014).

  23. 23.

    & Upf1 senses 3′ UTR length to potentiate mRNA decay. Cell 143, 379–389 (2010).

  24. 24.

    & Rules that govern UPF1 binding to mRNA 3′ UTRs. Proc. Natl Acad. Sci. USA 110, 3357–3362 (2013).

  25. 25.

    , & Global analyses of UPF1 binding and function reveal expanded scope of nonsense-mediated mRNA decay. Genome Res. 23, 1636–1650 (2013).

  26. 26.

    , , & Translation-dependent displacement of UPF1 from coding sequences causes its enrichment in 3′ UTRs. Nat. Struct. Mol. Biol. 20, 936–943 (2013).

  27. 27.

    et al. MOV10 is a 5′ to 3′ RNA helicase contributing to UPF1 mRNA target degradation by translocation along 3′ UTRs. Mol. Cell 54, 573–585 (2014). References 11 and 23–27 suggest that UPF1 binding to RNA is non-specific and does not discriminate NMD from non-NMD substrates, but that it becomes specific following NMD activation.

  28. 28.

    et al. The surveillance complex interacts with the translation release factors to enhance termination and degrade aberrant mRNAs. Genes Dev. 12, 1665–1677 (1998).

  29. 29.

    , , & The role of Upf proteins in modulating the translation read-through of nonsense-containing transcripts. EMBO J. 20, 880–890 (2001).

  30. 30.

    et al. A faux 3′-UTR promotes aberrant termination and triggers nonsense-mediated mRNA decay. Nature 432, 112–118 (2004).

  31. 31.

    & The RNA helicase DHX34 activates NMD by promoting a transition from the surveillance to the decay-inducing complex. Cell Rep. 8, 1845–1856 (2014).

  32. 32.

    & The elongation, termination, and recycling phases of translation in eukaryotes. Cold Spring Harb. Perspect. Biol. 4, a013706 (2012).

  33. 33.

    , , , & A conserved role for cytoplasmic poly(A)-binding protein 1 (PABPC1) in nonsense-mediated mRNA decay. EMBO J. 26, 1591–1601 (2007).

  34. 34.

    , , , & Posttranscriptional gene regulation by spatial rearrangement of the 3′ untranslated region. PLoS Biol. 6, e92 (2008).

  35. 35.

    , , , & Proximity of the poly(A)-binding protein to a premature termination codon inhibits mammalian nonsense-mediated mRNA decay. RNA 14, 563–576 (2008).

  36. 36.

    , & A competition between stimulators and antagonists of Upf complex recruitment governs human nonsense-mediated mRNA decay. PLoS Biol. 6, e111 (2008).

  37. 37.

    , , , & The eukaryotic polypeptide chain releasing factor (eRF3/GSPT) carrying the translation termination signal to the 3′-poly(A) tail of mRNA. Direct association of eRF3/GSPT with polyadenylate-binding protein. J. Biol. Chem. 274, 16677–16680 (1999).

  38. 38.

    et al. Poly(A)-binding protein acts in translation termination via eukaryotic release factor 3 interaction and does not influence [PSI+] propagation. Mol. Cell. Biol. 22, 3301–3315 (2002).

  39. 39.

    & Molecular basis of eRF3 recognition by the MLLE domain of poly(A)-binding protein. PLoS ONE 5, e10169 (2010).

  40. 40.

    , , & Eukaryotic initiation factor 4G suppresses nonsense-mediated mRNA decay by two genetically separable mechanisms. PLoS ONE 9, e104391 (2014).

  41. 41.

    , , & The interaction of cytoplasmic poly(A)-binding protein with eukaryotic initiation factor 4G suppresses nonsense-mediated mRNA decay. RNA 20, 1579–1592 (2014). References 40 and 41 show that the ability of PTC-proximal PABPC to render a transcript resistant to NMD depends on its interaction with eIF4G.

  42. 42.

    , , & Circularization of mRNA by eukaryotic translation initiation factors. Mol. Cell 2, 135–140 (1998).

  43. 43.

    , , , & Mammalian poly(A)-binding protein is a eukaryotic translation initiation factor, which acts via multiple mechanisms. Genes Dev. 19, 104–113 (2005).

  44. 44.

    , , & Translation factors promote the formation of two states of the closed-loop mRNP. Nature 453, 1276–1280 (2008).

  45. 45.

    et al. Nonsense mutations in close proximity to the initiation codon fail to trigger full nonsense-mediated mRNA decay. J. Biol. Chem. 279, 32170–32180 (2004).

  46. 46.

    et al. Mechanism of escape from nonsense-mediated mRNA decay of human β-globin transcripts with nonsense mutations in the first exon. RNA 17, 843–854 (2011).

  47. 47.

    et al. Interaction of PABPC1 with the translation initiation complex is critical to the NMD resistance of AUG-proximal nonsense mutations. Nucleic Acids Res. 40, 1160–1173 (2012). This reference provides evidence that the interaction between PABPC and eIF4G is crucial for rendering a mRNA containing a termination codon close to the start codon resistant to NMD.

  48. 48.

    , , , & EJC-independent degradation of nonsense immunoglobulin-μ mRNA depends on 3′ UTR length. Nat. Struct. Mol. Biol. 13, 462–464 (2006).

  49. 49.

    , , , & Autoregulation of the nonsense-mediated mRNA decay pathway in human cells. RNA 17, 2108–2118 (2011).

  50. 50.

    , , & Identification of elements in human long 3′ UTRs that inhibit nonsense-mediated decay. RNA 21, 887–897 (2015).

  51. 51.

    , , & The spliceosome deposits multiple proteins 20–24 nucleotides upstream of mRNA exon–exon junctions. EMBO J. 19, 6860–6869 (2000).

  52. 52.

    et al. The cellular EJC interactome reveals higher-order mRNP structure and an EJC-SR protein nexus. Cell 151, 750–764 (2012).

  53. 53.

    et al. CLIP–seq of eIF4AIII reveals transcriptome-wide mapping of the human exon junction complex. Nat. Struct. Mol. Biol. 19, 1124–1131 (2012).

  54. 54.

    , , & The exon–exon junction complex provides a binding platform for factors involved in mRNA export and nonsense-mediated mRNA decay. EMBO J. 20, 4987–4997 (2001).

  55. 55.

    , & Role of the nonsense-mediated decay factor hUpf3 in the splicing-dependent exon-exon junction complex. Science 293, 1832–1836 (2001).

  56. 56.

    , & Communication of the position of exon-exon junctions to the mRNA surveillance machinery by the protein RNPS1. Science 293, 1836–1839 (2001).

  57. 57.

    , , , & Y14 and hUpf3b form an NMD-activating complex. Mol. Cell 11, 939–949 (2003).

  58. 58.

    & A rule for termination-codon position within intron-containing genes: when nonsense affects RNA abundance. Trends Biochem. Sci. 23, 198–199 (1998).

  59. 59.

    et al. SMG-8 and SMG-9, two novel subunits of the SMG-1 complex, regulate remodeling of the mRNA surveillance complex during nonsense-mediated mRNA decay. Genes Dev. 23, 1091–1105 (2009).

  60. 60.

    et al. The nonsense-mediated mRNA decay SMG-1 kinase is regulated by large-scale conformational changes controlled by SMG-8. Genes Dev. 25, 153–164 (2011).

  61. 61.

    et al. Structures of SMG1-UPFs complexes: SMG1 contributes to regulate UPF2-dependent activation of UPF1 in NMD. Structure 22, 1105–1119 (2014).

  62. 62.

    et al. Upf1 phosphorylation triggers translational repression during nonsense-mediated mRNA decay. Cell 133, 314–327 (2008).

  63. 63.

    & Nonsense-mediated messenger RNA decay is initiated by endonucleolytic cleavage in Drosophila. Nature 429, 575–578 (2004).

  64. 64.

    , , & Structures of the PIN domains of SMG6 and SMG5 reveal a nuclease within the mRNA surveillance complex. EMBO J. 25, 5117–5125 (2006).

  65. 65.

    , , , & SMG6 is the catalytic endonuclease that cleaves mRNAs containing nonsense codons in metazoan. RNA 14, 2609–2617 (2008).

  66. 66.

    , , & SMG6 promotes endonucleolytic cleavage of nonsense mRNA in human cells. Nat. Struct. Mol. Biol. 16, 49–55 (2009).

  67. 67.

    et al. Identification of SMG6 cleavage sites and a preferred RNA cleavage motif by global analysis of endogenous NMD targets in human cells. Nucleic Acids Res. 43, 309–323 (2014).

  68. 68.

    et al. Human nonsense-mediated RNA decay initiates widely by endonucleolysis and targets snoRNA host genes. Genes Dev. 28, 2498–2517 (2014). References 67 and 68 use transcriptome-wide approaches that identify NMD-responsive mRNAs and NMD-specific degradation intermediates, to improve the probability of finding direct NMD targets.

  69. 69.

    & SMG7 acts as a molecular link between mRNA surveillance and mRNA decay. Mol. Cell 16, 587–596 (2004).

  70. 70.

    et al. Concerted action of poly(A) nucleases and decapping enzyme in mammalian mRNA turnover. Nat. Struct. Mol. Biol. 12, 1054–1063 (2005).

  71. 71.

    , & The SMG5–SMG7 heterodimer directly recruits the CCR4–NOT deadenylase complex to mRNAs containing nonsense codons via interaction with POP2. Genes Dev. 27, 2125–2138 (2013).

  72. 72.

    , & Human proline-rich nuclear receptor coregulatory protein 2 mediates an interaction between mRNA surveillance machinery and decapping complex. Mol. Cell 33, 75–86 (2009).

  73. 73.

    et al. Structural basis of the PNRC2-mediated link between mRNA surveillance and decapping. Structure 20, 2025–2037 (2012).

  74. 74.

    et al. SMG5-PNRC2 is functionally dominant compared with SMG5-SMG7 in mammalian nonsense-mediated mRNA decay. Nucleic Acids Res. 41, 1319–1328 (2013).

  75. 75.

    , & SMG-5, required for C. elegans nonsense-mediated mRNA decay, associates with SMG-2 and protein phosphatase 2A. EMBO J. 22, 641–650 (2003).

  76. 76.

    et al. Inhibition of nonsense-mediated mRNA decay (NMD) by a new chemical molecule reveals the dynamic of NMD factors in P-bodies. J. Cell Biol. 178, 1145–1160 (2007).

  77. 77.

    , , , & Nonsense surveillance regulates expression of diverse classes of mammalian transcripts and mutes genomic noise. Nat. Genet. 36, 1073–1078 (2004).

  78. 78.

    , & hUPF2 silencing identifies physiologic substrates of mammalian nonsense-mediated mRNA decay. Mol. Cell. Biol. 26, 1272–1287 (2006).

  79. 79.

    et al. Ultraconserved elements are associated with homeostatic control of splicing regulators by alternative splicing and nonsense-mediated decay. Genes Dev. 21, 708–718 (2007).

  80. 80.

    et al. Regulation of multiple core spliceosomal proteins by alternative splicing-coupled nonsense-mediated mRNA decay. Mol. Cell. Biol. 28, 4320–4330 (2008).

  81. 81.

    et al. NMD is essential for hematopoietic stem and progenitor cells and for eliminating by-products of programmed DNA rearrangements. Genes Dev. 22, 1381–1396 (2008).

  82. 82.

    et al. UPF2 is a critical regulator of liver development, function and regeneration. PLoS ONE 5, e11650 (2010).

  83. 83.

    et al. Smg1 is required for embryogenesis and regulates diverse genes via alternative splicing coupled to nonsense-mediated mRNA decay. Proc. Natl Acad. Sci. USA 107, 12186–12191 (2010).

  84. 84.

    et al. Inhibition of nonsense-mediated RNA decay by the tumor microenvironment promotes tumorigenesis. Mol. Cell. Biol. 31, 3670–3680 (2011).

  85. 85.

    et al. Mammalian tissues defective in nonsense-mediated mRNA decay display highly aberrant splicing patterns. Genome Biol. 13, R35 (2012). References 81, 82 and 85 demonstrate the roles of NMD in various physiological processes.

  86. 86.

    et al. Identification of hundreds of novel UPF1 target transcripts by direct determination of whole transcriptome stability. RNA Biol. 9, 1370–1379 (2012). References 84 and 86 measure mRNA half-lives in control and NMD-inhibited conditions, to identify direct targets of NMD.

  87. 87.

    et al. Transcriptome profiling of UPF3B/NMD-deficient lymphoblastoid cells from patients with various forms of intellectual disability. Mol. Psychiatry 17, 1103–1115 (2012).

  88. 88.

    et al. Contribution of copy number variants involving nonsense-mediated mRNA decay pathway genes to neuro-developmental disorders. Hum. Mol. Genet. 22, 1816–1825 (2013).

  89. 89.

    et al. Orchestrated intron retention regulates normal granulocyte differentiation. Cell 154, 583–595 (2013).

  90. 90.

    Hypoxic inhibition of nonsense-mediated RNA decay regulates gene expression and the integrated stress response. Mol. Cell. Biol. 28, 3729–3741 (2008).

  91. 91.

    & Stress-induced inhibition of nonsense-mediated RNA decay regulates intracellular cystine transport and intracellular glutathione through regulation of the cystine/glutamate exchanger SLC7A11. Oncogene 34, 4211–4218 (2015).

  92. 92.

    et al. The unfolded protein response affects readthrough of premature termination codons. EMBO Mol. Med. 6, 685–701 (2014).

  93. 93.

    et al. The unfolded protein response is shaped by the NMD pathway. EMBO Rep. 16, 599–609 (2015). This reference provides evidence that NMD shapes the cellular threshold of ER stress by restricting the levels of mRNAs encoding proteins that are involved in the UPR.

  94. 94.

    , , , & Unproductive splicing of SR genes associated with highly conserved and ultraconserved DNA elements. Nature 446, 926–929 (2007). References 79, 80, 85 and 94 describe the widespread use of AS–NMD in transcripts of splicing factors. Reference 85 shows that some splicing factors are misregulated in UPF2-deficient mouse cells, which leads to a general increase in alternative splicing.

  95. 95.

    & Growth arrest on inhibition of nonsense-mediated decay is mediated by noncoding RNA GAS5. Biomed. Res. Int. 2013, 358015 (2013).

  96. 96.

    , & The RNA degradation pathway regulates the function of GAS5 a non-coding RNA in mammalian cells. PLoS ONE 8, e55684 (2013).

  97. 97.

    et al. SNORD-host RNA Zfas1 is a regulator of mammary development and a potential marker for breast cancer. RNA 17, 878–891 (2011).

  98. 98.

    , , & Crystal structure of the UPF2-interacting domain of nonsense-mediated mRNA decay factor UPF1. RNA 12, 1817–1824 (2006).

  99. 99.

    et al. Upf1 potentially serves as a RING-related E3 ubiquitin ligase via its association with Upf3 in yeast. RNA 14, 1950–1958 (2008).

  100. 100.

    , & Upf1 stimulates degradation of the product derived from aberrant messenger RNA containing a specific nonsense mutation by the proteasome. EMBO Rep. 10, 1265–1271 (2009).

  101. 101.

    , , & The Upf factor complex interacts with aberrant products derived from mRNAs containing a premature termination codon and facilitates their proteasomal degradation. J. Biol. Chem. 288, 28630–28640 (2013).

  102. 102.

    , , & CBP80-promoted mRNP rearrangements during the pioneer round of translation, nonsense-mediated mRNA decay, and thereafter. Cold Spring Harb. Symp. Quant. Biol. 75, 127–134 (2010).

  103. 103.

    & Nonsense-mediated mRNA decay occurs during eIF4F-dependent translation in human cells. Nat. Struct. Mol. Biol. 20, 702–709 (2013).

  104. 104.

    & eIF4E-bound mRNPs are substrates for nonsense-mediated mRNA decay in mammalian cells. Nat. Struct. Mol. Biol. 20, 710–717 (2013).

  105. 105.

    , , & Communication with the exon-junction complex and activation of nonsense-mediated decay by human Upf proteins occur in the cytoplasm. Mol. Cell 27, 780–792 (2007).

  106. 106.

    & Nonsense-mediated decay in genetic disease: friend or foe? Mutat. Res. Rev. Mutat. Res. 762, 52–64 (2014).

  107. 107.

    , , & Nonsense-mediated decay approaches the clinic. Nat. Genet. 36, 801–808 (2004).

  108. 108.

    , & Nonsense-mediated mRNA decay modulates clinical outcome of genetic disease. Eur. J. Hum. Genet. 14, 1074–1081 (2006).

  109. 109.

    in Molecular Genetic Pathology (eds Cheng, L., Zhang, D. Y. & Eble, J. N.) 825–856 (Springer New York, 2012).

  110. 110.

    & Nonsense surveillance in lymphocytes? Immunity 8, 135–141 (1998).

  111. 111.

    & The functional consequences of intron retention: alternative splicing coupled to NMD as a regulator of gene expression. Bioessays 36, 236–243 (2014).

  112. 112.

    , , , & The coupling of alternative splicing and nonsense-mediated mRNA decay. Adv. Exp. Med. Biol. 623, 190–211 (2007).

  113. 113.

    , , , & Quality control of transcription start site selection by nonsense-mediated-mRNA decay. eLife 4, e06722 (2015).

  114. 114.

    , , & Regulation of axon guidance by compartmentalized nonsense-mediated mRNA decay. Cell 153, 1252–1265 (2013). This reference demonstrates that proper spatial expression of the ROBO3.2 receptor is controlled by localized translation and NMD-targeting of the Robo3.2 mRNA in certain axonal growth cones.

  115. 115.

    , , , & SC35 autoregulates its expression by promoting splicing events that destabilize its mRNAs. EMBO J. 20, 1785–1796 (2001).

  116. 116.

    , , , & Autoregulation of polypyrimidine tract binding protein by alternative splicing leading to nonsense-mediated decay. Mol. Cell 13, 91–100 (2004).

  117. 117.

    et al. Widespread intron retention in mammals functionally tunes transcriptomes. Genome Res. 24, 1774–1786 (2014).

  118. 118.

    , & A perspective on mammalian upstream open reading frame function. Int. J. Biochem. Cell Biol. 45, 1690–1700 (2013).

  119. 119.

    et al. High resolution transcriptome maps for wild-type and nonsense-mediated decay-defective Caenorhabditis elegans. Genome Biol. 10, R101 (2009).

  120. 120.

    & Reinitiation involving upstream ORFs regulates ATF4 mRNA translation in mammalian cells. Proc. Natl Acad. Sci. USA 101, 11269–11274 (2004).

  121. 121.

    Mechanisms and implications of programmed translational frameshifting. Wiley Interdiscip. Rev. RNA 3, 661–673 (2012).

  122. 122.

    et al. Ribosomal frameshifting in the CCR5 mRNA is regulated by miRNAs and the NMD pathway. Nature 512, 265–269 (2014).

  123. 123.

    & Selenocysteine incorporation: a trump card in the game of mRNA decay. Biochimie 114, 97–101 (2015).

  124. 124.

    & Selenium regulation of the selenoprotein and nonselenoprotein transcriptomes in rodents. Adv. Nutr. 2, 138–150 (2011).

  125. 125.

    & Nonsense-mediated decay factors are involved in the regulation of selenoprotein mRNA levels during selenium deficiency. RNA 20, 1248–1256 (2014).

  126. 126.

    , & Post-transcriptional defects of antioxidant selenoenzymes cause oxidative stress under methylmercury exposure. J. Biol. Chem. 286, 6641–6649 (2011).

  127. 127.

    et al. Rent1, a trans-effector of nonsense-mediated mRNA decay, is essential for mammalian embryonic viability. Hum. Mol. Genet. 10, 99–105 (2001).

  128. 128.

    et al. Smg6/Est1 licenses embryonic stem cell differentiation via nonsense-mediated mRNA decay. EMBO J. 34, 1630–1647 (2015). This reference shows that viable SMG6-deficient ES cells fail to differentiate and that NMD, and not telomere maintenance, is the crucial activity underlying this defect.

  129. 129.

    , & Up-frameshift protein 1 (UPF1): multitalented entertainer in RNA decay. Drug Discov. Ther. 6, 55–61 (2012).

  130. 130.

    & UPF1 involvement in nuclear functions. Biochem. Soc. Trans. 40, 778–783 (2012).

  131. 131.

    & Regulated degradation of replication-dependent histone mRNAs requires both ATR and Upf1. Nat. Struct. Mol. Biol. 12, 794–800 (2005).

  132. 132.

    , , , & SMD and NMD are competitive pathways that contribute to myogenesis: effects on PAX3 and myogenin mRNAs. Genes Dev. 23, 54–66 (2009).

  133. 133.

    , , , & The UPF3B gene, implicated in intellectual disability, autism, ADHD and childhood onset schizophrenia regulates neural progenitor cell behaviour and neuronal outgrowth. Hum. Mol. Genet. 22, 4673–4687 (2013).

  134. 134.

    et al. Posttranscriptional control of the stem cell and neurogenic programs by the nonsense-mediated RNA decay pathway. Cell Rep. 6, 748–764 (2014).

  135. 135.

    et al. Identification of a microRNA that activates gene expression by repressing nonsense-mediated RNA decay. Mol. Cell 42, 500–510 (2011). References 134 and 135 show that specific miRNAs target NMD factors to downregulate the activity of NMD, and that this is necessary for the differentiation of neuronal progenitor cells into neurons.

  136. 136.

    , & This message will self-destruct: NMD regulates axon guidance. Cell 153, 1185–1187 (2013).

  137. 137.

    et al. Mutations in UPF3B, a member of the nonsense-mediated mRNA decay complex, cause syndromic and nonsyndromic mental retardation. Nat. Genet. 39, 1127–1133 (2007).

  138. 138.

    & Reprogramming mRNA translation during stress. Curr. Opin. Cell Biol. 20, 222–226 (2008).

  139. 139.

    et al. Intracellular calcium regulates nonsense-mediated mRNA decay. Nat. Med. 20, 961–966 (2014).

  140. 140.

    et al. A novel role for hSMG-1 in stress granule formation. Mol. Cell. Biol. 31, 4417–4429 (2011).

  141. 141.

    & Staufen-mediated mRNA decay. Wiley Interdiscip. Rev. RNA 4, 423–435 (2013).

  142. 142.

    et al. Molecular mechanisms for the RNA-dependent ATPase activity of Upf1 and its regulation by Upf2. Mol. Cell 41, 693–703 (2011).

  143. 143.

    et al. Unusual bipartite mode of interaction between the nonsense-mediated decay factors, UPF1 and UPF2. EMBO J. 28, 2293–2306 (2009).

  144. 144.

    , & Tight intramolecular regulation of the human Upf1 helicase by its N- and C-terminal domains. Nucleic Acids Res. 41, 2404–2415 (2013).

Download references

Acknowledgements

The authors apologize to those researchers whose work was not cited due to space limitations, and thank Christian Kroun Damgaard, Jens Lykke-Andersen and four insightful reviewers for their critical assessments of the manuscript. Research in the authors' laboratory is funded by the European Research Council, the Danish National Research Foundation (grant DNRF58), the Lundbeck Foundation and the Novo Nordisk Foundation.

Author information

Affiliations

  1. Centre for mRNP Biogenesis and Metabolism, Department of Molecular Biology and Genetics, Aarhus University, DK-8000 Aarhus, Denmark.

    • Søren Lykke-Andersen
    •  & Torben Heick Jensen

Authors

  1. Search for Søren Lykke-Andersen in:

  2. Search for Torben Heick Jensen in:

Competing interests

The authors declare no competing financial interests.

Corresponding authors

Correspondence to Søren Lykke-Andersen or Torben Heick Jensen.

Supplementary information

PDF files

  1. 1.

    Supplementary information S1 (figure)

    PTC-generating events.

Glossary

Exon–junction complex

(EJC). A complex deposited upstream of most exon–exon junctions following splicing. The EJC stimulates export and translation.

Deadenylase

A 3′–5′ exoribonuclease with specificity for poly(A) moieties.

General decapping complex

A protein complex responsible for the hydrolysis of the 7-methylguanosine (m7G) cap situated at mRNA 5′ ends.

β-thalassaemia

A blood disorder caused by mutations in the β-globin (HBB) gene on chromosome 11, which leads to reduced or absent production of haemoglobin β-chains.

Haploinsufficiency

A phenotype caused by the insufficient expression of a functional factor as a result of a mutation in one of the two encoding alleles.

Waardenburg syndrome type 4C

An auditory–pigmentary syndrome that is characterized by pigmentary abnormalities of the eye, deafness and gastrointestinal disease.

Integrated stress response

Various cellular stresses that act (partly) through the inactivation of the eukaryotic translation initiation factor subunit eIF2.

Programmed ribosomal frameshifting

A shift of the reading frame by one or two nucleotides (in the 5′ or 3′ direction), directed by a mRNA structural element.

Selenoproteins

Proteins containing one or more of the non-conventional amino acid selenocysteine.

Selenocysteine insertion sequence

(SECIS). A 60 nt RNA sequence element situated downstream of a UGA termination codon in selenoprotein-coding mRNAs.

Histone mRNA degradation

An up frameshift 1 (UPF1)-dependent degradation mechanism mediated by its binding of stem–loops at the 3′ end of replication-dependent histone mRNAs.

Staufen 1-mediated mRNA decay

(SMD). The degradation of substrates with extended double-stranded 3′ UTR structures that bind one, or both, of the up frameshift 1 (UPF1)-recruiting Staufen paralogues STAU1 and STAU2.

Axonal growth cones

Dynamic extensions at the tips of axons. Growth cones are able to rapidly change direction and branch in response to stimuli.

Commissural neurons

A tract of nerve fibres passing from one side to the other of the spinal cord or the brain.

About this article

Publication history

Published

DOI

https://doi.org/10.1038/nrm4063

Further reading